Post-earnings recap
Reported
Thu, Jan 30, 2014
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
75%
Eli Lilly reported an EPS of $0.74, which was a slight beat, but the stock reacted negatively, declining by 1.19%. The lack of revenue data and management commentary may have contributed to investor uncertainty. Overall, the mixed results suggest cautious sentiment among investors.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.74 | N/A | +0.82% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—